Jeffrey John Ronald Jr.

Director Jeffrey John Ronald Jr. sells majority of AGX stake in near-record-high market, timing raises questions on conviction.

Jeffrey John Ronald Jr., a member of Argan's board, liquidated more than half his holdings in a single transaction as the stock traded near its yearly peak and following a sharp recovery period. The director's sale of over $1.7 million in shares is substantial and points toward a reduction in his personal conviction at this valuation level—particularly notable because the sale comes after the stock has rebounded sharply. While Argan remains fundamentally healthy with steady revenue growth and strong profitability, the timing suggests Ronald may view current prices as attractive for diversifying his personal wealth rather than a vote of confidence in future upside. The sale itself is not alarming in isolation, but paired with the stock's stretched valuation relative to its recent momentum, it warrants attention as a potential signal that insiders are taking chips off the table.

Director Jeffrey John Ronald Jr. sold 3,636 shares of AGX at $615.40, reducing holdings by 43.6%; stock now at $651.68.

Director Jeffrey John Ronald Jr. sold 3,636 shares of ARGAN INC at $615.40 on 2026-04-21, reducing his holdings from 8,334 to 4,698 shares—a 43.6% reduction in position. The stock has since moved to $651.68, reflecting a +5.9% move above the sale price. Across his prior trades at AGX, only 1 of 3 measurable sales at the 90-day mark resulted in subsequent stock declines (33% well-timed rate), and his most recent same-ticker sale on 2026-03-31 remains outcome-indeterminate. The company shows solid fundamentals with $251.2M quarterly revenue, $30.7M net income, and 8.1% annual revenue growth, though the stock trades at a high 52.77 P/E ratio and recently surged +40.7% over 30 days and +71.3% over 90 days—levels at which a substantial director reduction warrants observer attention for whether it signals reduced conviction at current valuations.

Director Jeffrey John Ronald Jr. sold 4,556 shares of AGX at $539.85; stock now at $575.16 (+0.0% from 52-week high, +31.0% in 30 days)

Director Jeffrey John Ronald Jr. sold 4,556 shares (55.6% of his pre-transaction holdings) on 2026-03-31 at $539.85, reducing his stake from 8,192 to 3,636 shares for a total transaction value of $2,459,556.60. The sale occurred as the stock approaches its 52-week high of $575.16, having gained +31.0% over the prior 30 days and +76.4% over 90 days. At AGX specifically, Ronald's prior four trades show mixed timing outcomes: two recent sells (2026-01-27 and 2026-01-20) realized gains of +25.4% and +13.6% respectively within 30 days, while a 2025-09-29 sale delivered +21.0% return at the 90-day mark, though a 2025-06-09 sale declined -2.9% over 90 days. Against his cross-ticker record of 50% well-timed sells at the 90-day mark (averaging +9.1% returns), his same-ticker pattern at AGX is less decisive—only 1 of 2 measurable 90-day outcomes was negative. The stock's valuation remains elevated at 46.57x P/E on $251.2M quarterly revenue and $30.7M net income, with an $8.0B market cap.

Director Jeffrey John Ronald Jr. sold 2,700 shares of AGX at $380.60 (Jan 20), holding 13,192 post-sale; stock now at $397.42.

Jeffrey John Ronald Jr. sold 2,700 shares at $380.60 on 2026-01-20, reducing his stake from 15,892 to 13,192 shares (a -17.0% reduction in holdings). The sale occurred near the 52-week high of $397.42, with the stock appreciating +17.6% over the prior 30 days and +43.9% over 90 days. His cross-ticker track record across 2 prior sales shows an average 90-day return of +9.1%, with a well-timed rate of 50.00%; at AGX specifically, he has 1 prior sale that was well-timed (Sept 2025: +8.8% in 30 days, +21.0% in 90 days) and 1 that was not (June 2025: -5.1% in 30 days, -2.9% in 90 days). The company's fundamentals remain strong with annual revenue growth of +52.5%, net income of $30.7M on $251.2M quarterly revenue, and a P/E of 46.00.

Director Jeffrey John Ronald Jr. sold 4,698 shares of ARGAN INC (AGX) at $268.60 for $1,261,882.80; position halved to 4,556 shares.

Director Jeffrey John Ronald Jr. sold 4,698 shares (4.7K shares) at $268.60 on 2025-09-29, reducing his holdings by 50.8% from 9,254 to 4,556 shares. The sale occurred near the 52-week high of $279.62—trading $279.62 is at the 52-week high, only 4.1% above the transaction price. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100%, and his prior AGX sale on 2025-06-09 also posted negative 90-day returns (-2.9%), suggesting a pattern of selling ahead of weakness. With AGX trading at a P/E of 32.94 on strong fundamentals (52.5% annual revenue growth, $35.3M net income on $237.7M quarterly revenue), the material reduction in insider holdings—particularly a 50.8% net reduction from the director's position—warrants observation alongside the stock's recent 32.5% 90-day appreciation and stretched valuation.

Director Jeffrey John Ronald Jr. sold 5,500 shares of AGX at $217.79 (June 9), retaining 11,875 shares post-sale.

Director Jeffrey John Ronald Jr. sold 5,500 shares (31.7% reduction from 17,375 shares held pre-transaction) at $217.79 per share, generating $1,197,845.00 in proceeds. AGX has experienced strong recent momentum—90-day change of +97.6% and 30-day change of +31.5%—while the company has grown annual revenue by 52.5% and maintains a P/E ratio of 30.56 on a $3.1B market cap. The sale occurred at a price 7.7% below the 52-week high of $243.11, and the director retains meaningful holdings (11,875 shares), indicating continued ownership stake in the company. The transaction captures a discrete disposal decision by a director of a highly appreciated, rapidly growing company trading at elevated valuation multiples.